NCT06279442 Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
| NCT ID | NCT06279442 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Latin American Cooperative Oncology Group |
| Condition | Carcinoma Adrenal |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-10-09 |
| Primary Completion | 2025-08-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2024-10-09 with a primary completion date of 2025-08-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a retrospective observational cohort study. The clinical, pathological and treatment data of participants identified with adrenocortical carcinoma from the year 2000 onwards will be evaluated. Participants recruited for this study will be identified at the participating sites.
Eligibility Criteria
Inclusion Criteria: * Participants over 18 years old; * Diagnosis of adrenocortical carcinoma with at least one clinical evaluation at the reference institution; * Initial diagnosis or recurrence from the year 2000 onwards. Exclusion Criteria: * Participants with insufficient clinical or pathological data in the medical records.
Contact & Investigator
Milena Shizue Tariki
PRINCIPAL INVESTIGATOR
Latin American Cooperative Oncology Group
Frequently Asked Questions
Who can join the NCT06279442 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Carcinoma Adrenal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06279442 currently recruiting?
Yes, NCT06279442 is actively recruiting participants. Contact the research team at giana.corssac@lacogcancerresearch.org for enrollment information.
Where is the NCT06279442 trial being conducted?
This trial is being conducted at Fortaleza, Brazil, São Luís, Brazil, Curitiba, Brazil, Recife, Brazil and 6 additional locations.
Who is sponsoring the NCT06279442 clinical trial?
NCT06279442 is sponsored by Latin American Cooperative Oncology Group. The principal investigator is Milena Shizue Tariki at Latin American Cooperative Oncology Group. The trial plans to enroll 150 participants.